Lyophilized Peptides: How Freeze-Drying Works (2026)

Lyophilized peptides are peptides that have been freeze-dried: frozen in solution, then dried under vacuum so the ice turns straight to vapour, leaving a dry solid called a cake. The process has three stages (freezing, primary drying and secondary drying) and typically leaves a few percent of residual water. Peptides are supplied this way because removing water slows the chemical reactions that break them down in solution, so a sealed lyophilized vial is far more stable in storage and transit than the same peptide dissolved.

Lyophilized peptides at a glance

Source: Tang and Pikal [1]; Nail et al. [2]; Templeton et al. [8].

What is lyophilization?

Lyophilization, or freeze-drying, removes water from a frozen material by sublimation: below the triple point of water, ice turns directly into vapour without passing through a liquid phase. Drying from the frozen state keeps the solid’s structure in place, so the product ends up as a porous, low-density cake that occupies roughly the volume of the original frozen fill.

It is the most common way to prepare solid protein products that are not stable enough to keep in solution, and the same logic applies to peptides [6]. The same review notes the trade-off: freezing and drying can each denature proteins, and a dry solid still degrades slowly [6]. Lyophilization slows chemistry. It does not stop it.

For synthetic peptides, freeze-drying is also the final step of manufacture. After purification by preparative HPLC, the peptide is in a dilute water and acetonitrile solution, and lyophilization is how it is isolated as a solid. Our explainer on how peptides are made covers the steps before this one.

The three stages of freeze-drying

1. Freezing

When the solution is cooled, it usually supercools below 0 °C before the first ice crystals form. The temperature at which that happens, the nucleation temperature, varies from vial to vial at random. It matters because it sets the size of the ice crystals, and the ice crystals become the pores of the finished cake. A higher nucleation temperature gives larger crystals, larger pores and a faster primary drying stage [4]. Controlled ice nucleation techniques were developed to make this step more uniform across a batch [4].

As ice forms, the peptide and any buffer salts are concentrated into a shrinking volume of unfrozen liquid between the crystals. That freeze-concentrate eventually solidifies, either as a crystalline eutectic or as an amorphous glass. Its glass transition temperature in the frozen state, written Tg’, is one of the key numbers in designing the process [1, 2].

2. Primary drying

In primary drying the chamber is put under vacuum and the shelves are warmed gently to supply the heat that sublimation consumes. Ice leaves from the top of the frozen fill downward, and the dried layer above the ice front becomes the main resistance to vapour flow [2]. This is usually the longest stage of the process.

The critical limit is the collapse temperature. If the product at the sublimation front gets warmer than this, the freeze-concentrate softens and flows before it is dry, and the pore structure falls in on itself. Process design picks a target product temperature a few degrees below the collapse temperature and then sets shelf temperature and chamber pressure to hold it there [1]. Collapse temperature can be measured directly by freeze-dry microscopy. In protein and sugar mixtures, the onset of collapse matched the DSC glass transition at low protein concentrations but not at higher ones, so the two measurements are not interchangeable [3].

3. Secondary drying

Not all the water freezes. A share stays bound in the amorphous solid, and primary drying does not remove it. Secondary drying raises the shelf temperature to drive this bound water off by desorption until a target residual moisture is reached [1]. Because sampling vials during the run is impractical, process monitoring estimates residual moisture from the measured desorption rate in the chamber [5].

At the end, the stoppers are pressed down into the vials while they are still inside the chamber, commonly under partial vacuum or dry nitrogen, and the vials are then capped with crimped aluminium seals.

Why peptides are shipped lyophilized

Water takes part in most of the reactions that degrade peptides. A review of solid-state chemistry lists the main ones as deamidation, peptide bond cleavage, oxidation, the Maillard reaction, beta-elimination, and dimerization or aggregation, and identifies temperature, moisture content, excipients and the physical state of the solid as the factors that control their rates [9]. Removing most of the water and holding the solid in a rigid glassy state slows molecular motion and these reactions with it.

The result is a material that tolerates storage and shipping far better than a solution. Our guide to storing lyophilized peptides covers temperature, light and moisture in detail, including what the literature says about transit at ambient temperature.

Lyophilized peptide cake appearance: what is normal

The ideal freeze-dried product is often described as a uniform, elegant cake. A group of freeze-drying specialists from industry and academia published a harmonised vocabulary for departures from that ideal, with representative images, and made a central point: a non-ideal appearance sometimes has no effect on product quality and is simply a characteristic of the formulation, the vial and the process [7].

Common appearance terms, and what they usually indicate:

• Shrinkage. The cake has pulled away from the vial wall. It is common and usually cosmetic.
• Cracking or fragmentation. The cake has split, during drying or later in handling. On its own it is cosmetic.
• Collapse or partial collapse. Loss of the porous structure, seen as a dense, glassy or shrunken mass. It indicates the product went above its collapse temperature during drying, and collapsed material tends to hold more residual water.
• Melt-back. Part of the frozen fill melted before it dried, leaving a dense or bubbled region, usually at the bottom of the vial.
• Dislodged or loose powder. The cake has broken up and moved, sometimes coating the stopper or the shoulder of the vial. This is typical after transit.

Peptide vials add one more consideration. A research vial may hold only a few milligrams of peptide, often with no bulking agent, so the solid can be a small pellet, a thin film or a loose scattering of powder rather than a tall cake. A small or patchy deposit is expected for low fill amounts and is not, by itself, evidence of a short fill. Net content is measured on the COA, not judged by eye.

Residual moisture in lyophilized peptides

Residual moisture is the water left in the solid after drying, usually reported as a percentage of the cake’s mass. It is one of the most important quality numbers for any freeze-dried product, because it governs how mobile the solid is and how fast degradation reactions proceed.

Evidence from protein products shows the effect clearly. In a lyophilized antibody formulation studied at residual moistures from 1% to 8%, the glass transition temperature fell from about 80 °C at 1% moisture to about 25 °C at 8% moisture. Higher moisture raised the rate of aspartate isomerization at elevated storage temperatures, and the authors concluded that high moisture lowered chemical stability whether the solid was glassy or rubbery [10]. All the formulations in that study were stable at 5 °C [10].

Moisture is measured in two main ways:

• Karl Fischer (KF) analysis is the reference method. It is destructive: the vial is opened and the sample is consumed.
• Near-infrared (NIR) spectroscopy reads moisture through the intact glass vial. In five products, NIR matched the precision of the Karl Fischer method, although changes in sugar content in the formulation shifted the NIR result because its signal overlapped with water’s [11].

Moisture can also arrive after drying. The water content of rubber stoppers changes with processing such as steam sterilisation and drying, and moisture transfers from the stopper to the dried product during storage. Stopper drying conditions were found to track the moisture levels later measured in the cake [8].

What to check when lyophilized peptides arrive

A sealed vial can be inspected without opening it. These checks cover the container, the solid and the paperwork:

1. Seal. The crimp cap should be intact and tight, with the stopper fully seated. A loose crimp or a raised stopper means the vial’s atmosphere may have been exposed to room air.
2. Glass. No cracks or chips, especially at the neck and base.
3. Solid. Dry powder, pellet, film or cake. Broken or dislodged material is common after shipping. Liquid, droplets, or a sticky, glassy, shrunken mass suggest moisture uptake or collapse.
4. Colour. Most lyophilized peptides are white to off-white. Some are coloured by design: copper-peptide complexes are blue, for example, and the GHK-Cu report on the Vortex COA page records a “blue lyophilized powder”.
5. Label. Compound name, amount and lot code where one is printed.
6. Lot match. The lot on the vial should match the lot on the published lab report, and the report date should fit the batch. Our guide to reading a peptide COA explains each field.

After inspection, the vial goes into cold, dry, dark storage, sealed. A vial taken out of cold storage collects condensation on its surfaces while it warms, so labs commonly let sealed vials reach room temperature before the seal is broken.

What a lyophilized peptide COA can and cannot tell you

The lab report describes the dried solid, not the drying process. HPLC purity measures the share of the peptide signal that is the target peptide. Net content measures how much of the solid is peptide by mass, which matters here because a lyophilized peptide is never only peptide. It also carries counter-ions from purification (often trifluoroacetate or acetate) and bound water. Our explainer on HPLC peptide purity testing covers the purity line, and our guide to endotoxin testing covers contaminant lines that appear on some reports.

Residual moisture is rarely printed on research-peptide reports. When it matters for a given experiment, it is a question to put to the supplier or the testing lab.

Frequently asked questions

What is lyophilization?

Lyophilization, or freeze-drying, removes water from a frozen material by sublimation under vacuum. It runs in three stages: freezing, primary drying, which removes the ice, and secondary drying, which removes water that never froze. The result is a porous dry solid called a cake.

Why are peptides supplied lyophilized?

Water takes part in most peptide degradation reactions, including deamidation, oxidation and peptide bond cleavage. Removing it and holding the peptide as a dry solid slows those reactions, so a sealed lyophilized vial is much more stable in storage and transit than a solution.

Is a cracked or loose cake a problem?

Usually not. Shrinkage, cracking and dislodged powder are common and generally cosmetic. Liquid in the vial, or a sticky, glassy, shrunken mass, is different: it suggests moisture uptake or collapse during drying.

Why does a 10 mg vial look almost empty?

A few milligrams of peptide without a bulking agent forms only a small pellet, film or scattering of powder. The amount in the vial is measured as net content on the lab report, not judged by the size of the deposit.

Research materials: Vortex supplies research peptides as lyophilized reagents in sealed vials: browse the catalogue. Lab reports by lot: /coa/.

References

1. Tang X, Pikal MJ. Design of freeze-drying processes for pharmaceuticals: practical advice. Pharm Res. 2004;21(2):191-200. PMID 15032301. doi:10.1023/b:pham.0000016234.73023.75
2. Nail SL, Jiang S, Chongprasert S, Knopp SA. Fundamentals of freeze-drying. Pharm Biotechnol. 2002;14:281-360. PMID 12189727. doi:10.1007/978-1-4615-0549-5_6
3. Meister E, Gieseler H. Freeze-dry microscopy of protein/sugar mixtures: drying behavior, interpretation of collapse temperatures and a comparison to corresponding glass transition data. J Pharm Sci. 2009;98(9):3072-87. PMID 18823013. doi:10.1002/jps.21586
4. Geidobler R, Winter G. Controlled ice nucleation in the field of freeze-drying: fundamentals and technology review. Eur J Pharm Biopharm. 2013;85(2):214-22. PMID 23643793. doi:10.1016/j.ejpb.2013.04.014
5. Fissore D, Pisano R, Barresi AA. Monitoring of the secondary drying in freeze-drying of pharmaceuticals. J Pharm Sci. 2011;100(2):732-42. PMID 20799368. doi:10.1002/jps.22311
6. Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1-2):1-60. PMID 10967427. doi:10.1016/s0378-5173(00)00423-3
7. Patel SM, Nail SL, Pikal MJ, et al. Lyophilized drug product cake appearance: what is acceptable? J Pharm Sci. 2017;106(7):1706-1721. PMID 28341598. doi:10.1016/j.xphs.2017.03.014
8. Templeton AC, Placek J, Xu H, Mahajan R, Hunke WA, Reed RA. Determination of the moisture content of bromobutyl rubber stoppers as a function of processing: implications for the stability of lyophilized products. PDA J Pharm Sci Technol. 2003;57(2):75-87. PMID 14674509
9. Lai MC, Topp EM. Solid-state chemical stability of proteins and peptides. J Pharm Sci. 1999;88(5):489-500. PMID 10229638. doi:10.1021/js980374e
10. Breen ED, Curley JG, Overcashier DE, Hsu CC, Shire SJ. Effect of moisture on the stability of a lyophilized humanized monoclonal antibody formulation. Pharm Res. 2001;18(9):1345-53. PMID 11683251. doi:10.1023/a:1013054431517
11. Lin TP, Hsu CC. Determination of residual moisture in lyophilized protein pharmaceuticals using a rapid and non-invasive method: near infrared spectroscopy. PDA J Pharm Sci Technol. 2002;56(4):196-205. PMID 12181804

Methods note: written by the Vortex Research Editorial Team. Literature was selected from PubMed for freeze-drying process and solid-state stability topics, and every PMID was checked against its PubMed record for title, journal and year. COA details were read from vortexresearch.net/coa/ on October 21, 2026.

Vortex Research products are sold for in-vitro laboratory research by qualified researchers. Not for human or veterinary use. Not a drug, dietary supplement or cosmetic. Statements have not been evaluated by the FDA.